Sangon Biotech Raises $10 Million from Qiming Ventures

Sangon Biotech, a Shanghai company that offers life science research services, has received $10 million in funding from Qiming Ventures. Sangon is a wholly owned subsidiary of Bio Basic Inc. of Toronto, a privately held enterprise that also offers life science research services. Sangon said it would use the funds to increase its R&D, manufacturing and sales. More details....